title: Comparative study of ureteral stents following endoureterotomy in the porcine model: 3 vs 6 weeks and 7F vs 14F.
abstract: The aim of the study was to determine the optimal stent size and stenting duration following retrograde endoureterotomy of experimental ureteral strictures. Twenty healthy Large White female pigs were randomly divided into four groups, depending on stent size (7F vs 14F) and stenting duration (3 weeks vs 6 weeks). Three additional pigs were used as the control group. The internal ureteral diameter was measured 2 cm below the lower pole of the right kidney. Histopathological changes of the urinary tract, ultrasonographic and fluoroscopic studies, urine culture, and serum urea and creatine levels were analyzed during the different phases of the study. The study was divided into three phases. Phase I included premodel documentation of the normal urinary tract and laparoscopic ureteral stricture creation. During the second phase 1 month later, the diagnosis and endourologic treatment of strictures were performed. Phase III began 4 weeks after stent removal; follow-up imaging studies and postmortem evaluation of all animals were performed. Ureteral strictures developed in all animals 4 weeks after model creation. Results from ureteral diameter measurements and pathological studies revealed no statistically significant intergroup differences. However, prevalence of urinary infection proved to be directly related to stent size (14F) and permanence (6 weeks). The chi square results suggest a statistically significant relationship between the urinary tract infection and recurrent strictures (alpha = 0.046). We recommend the use of 7F stents for a period of 3 weeks or less, as these are more easily positioned and result in the reduction of secondary side effects (lower infection rate, less intramural ureteral lesions). A significant relationship between urinary tract infection and stricture recurrence was found in this experimental study.
authors.affiliation: Endoscopy Department, Minimally Invasive Surgery Centre, Campus Universitario, Av. de la Universidad s/n, Cáceres, Spain. fsoria@ccmi.es
authors.forename: Federico
authors.initials: F
authors.lastname: Soria
authors.forename: Francisco M
authors.initials: FM
authors.lastname: Sánchez
authors.forename: Fei
authors.initials: F
authors.lastname: Sun
authors.forename: Javier
authors.initials: J
authors.lastname: Ezquerra
authors.forename: Esther
authors.initials: E
authors.lastname: Durán
authors.forename: Jesús
authors.initials: J
authors.lastname: Usón
mesh_terms: D000818:Animals; D003251:Constriction, Pathologic / Q000150:complications / Q000175:diagnosis / Q000601:surgery*; D004195:Disease Models, Animal; D005260:Female; D005500:Follow-Up Studies; D012008:Recurrence; D015607:Stents / Q000009:adverse effects; D013552:Swine; D013997:Time Factors; D016896:Treatment Outcome; D014463:Ultrasonography; D014513:Ureter / Q000000981:diagnostic imaging / Q000601:surgery*; D014515:Ureteral Diseases / Q000601:surgery*; D018666:Ureteroscopy / Q000009:adverse effects / Q000379:methods; D014552:Urinary Tract Infections / Q000209:etiology